📅 PUBMED DAILY TRIAGE — 2026-11-01 Window: 2026-10-31T09:00:00Z → 2026-11-01T09:00:00Z (CRDT) Topics scanned: 10 | Articles reviewed: 72 | Candidates evaluated: 74 High priority: 0 | Standard: 28 | Low/archive: 0 | Unsolicited finds: 4 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
- Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): No high-priority finds today (best candidate scored 6/10).
- CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best candidate scored 0/10).
- Early cancer detection (liquid biopsy, ctDNA, cfDNA): No high-priority finds today (best candidate scored 0/10).
- AI/ML in clinical diagnostics and imaging: No high-priority finds today (best candidate scored 6/10).
- Precision oncology and genomic medicine: No high-priority finds today (best candidate scored 7/10).
- Novel therapeutics: immunotherapy, CAR-T, targeted therapy: No high-priority finds today (best candidate scored 7/10).
- Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: No high-priority finds today (best candidate scored 7/10).
- Aging, longevity, and population health: No high-priority finds today (best candidate scored 6/10).
- Rare diseases with high unmet need: No high-priority finds today (best candidate scored 6/10).
🟢⚪ STANDARD (5-7) — Top by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
- PMID 42966630 · Transcriptomic Features Associated With Kinase Inhibitor Sensitivity in KMT2A-Rearranged AML. · 6/10 · Genomics/Precision Medicine
- PMID 42965891 · Morphological Characteristics and Diagnostic Challenges of Primary Thyroid Lymphoma in Fine-Needle Aspiration Cytology. · 6/10 · Diagnostics
- PMID 42966670 · Immune landscape and immunotherapeutic strategies for the treatment of TP53-mutated acute myeloid leukemia. · 5/10 · Treatment Innovation
- PMID 42965525 · Scalable Arrayed T-cell CRISPR Screening in Autologous Tumor Co-cultures to Prioritize Combination Partners for T-cell Engagers. · 5/10 · Drug Development
CBC-based diagnostics and machine learning in hematology
- No retained standard-priority articles.
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
- No retained standard-priority articles.
AI/ML in clinical diagnostics and imaging
- PMID 42966518 · Raman Spectroscopy for Glioma Diagnosis Toward Precision Neuro-Oncology: A Systematic Review. · 6/10 · Diagnostics
- PMID 42966635 · Salivary attenuated total reflectance-Fourier transform infrared spectroscopy in systemic diseases: a scoping review of clinical applications, spectral findings, and methodological challenges. · 5/10 · Diagnostics
- PMID 42966320 · Integrating single-cell and bulk RNA sequencing with ML algorithms identified MYBL2 as a candidate transcriptomic biomarker for diagnosing laryngeal squamous cell carcinoma (LSCC). · 5/10 · Diagnostics
- PMID 42966032 · Artificial intelligence in axial spondyloarthritis imaging: a review of current evidence. · 5/10 · Diagnostics
- PMID 42965887 · Large-Field Single-Cell Morphodynamic Scattering Imaging Enables Rapid, Heterogeneity-Resolved Phenotypic Antimicrobial Susceptibility Testing. · 5/10 · Diagnostics
Precision oncology and genomic medicine
- PMID 42966319 · The impact of PROgnostic SIgnatures in stage II colon cancer patients enrolled in the phase III clinical trial TOSCA: the PROSIT study. · 7/10 · Genomics/Precision Medicine
- PMID 42965781 · Reference frequencies of selected non-ICI genomic alterations detected through routine comprehensive genomic profiling in Japan: a nationwide C-CAT study. · 7/10 · Genomics/Precision Medicine
- PMID 42966626 · Route-aware Therapeutic Target Atlas for Desmoplastic Small Round Cell Tumor. · 6/10 · Drug Development
- PMID 42966632 · Multi-omics Profiling of Post-translational Modifications in RNA-binding Proteins in Colorectal Cancer. · 5/10 · Genomics/Precision Medicine
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
- PMID 42965526 · Local ablative treatment for oligoprogression during immunotherapy in metastatic non-small-cell lung cancer: a systematic review and meta-analysis. · 7/10 · Treatment Innovation
- PMID 42966454 · A tumor-microenvironment-responsive M1 macrophage-membrane-camouflaged nanoplatform potentiates polyphyllin VII immunotherapy through disrupting the ASNS-mTOR axis and inducing immunogenic cell death for solid tumor treatment. · 5/10 · Treatment Innovation
- PMID 42966058 · Mitochondrial transfer enhances the metabolic fitness and antitumor activity of primary NK cells. · 5/10 · Treatment Innovation
- PMID 42965843 · Knockdown of MAP7D2 regulates the immune-modulatory function mediated by CD8+ T cells and inhibits LUAD progression. · 5/10 · Treatment Innovation
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
- PMID 42966155 · Adjunctive fucoidan, fucoxanthin, and l-carnitine mitigate albuminuria and preserve eGFR over a 12-week treatment period in diabetic kidney disease: A translational study and proof-of-concept randomized clinical trial. · 7/10 · Treatment Innovation
- PMID 42966342 · Association of GLP-1 receptor agonist therapy with cardiovascular outcomes in patients with MASLD: A translational study. · 6/10 · Treatment Innovation
- PMID 42966230 · Temporal trends and projections of hypertension with hyperlipidemia-related mortality among US adults, 2000-2035: Insights from CDC WONDER database. · 6/10 · Public Health
- PMID 42966498 · Differentiated obesity treatment: Pharmacological CRF2 agonism drives fat loss, skeletal muscle hypertrophy and improved glucose metabolism in preclinical obesity. · 5/10 · Drug Development
- PMID 42966404 · SGLT2 inhibitor-induced genitourinary infections and the consequent antimicrobial-antidiabetic drug interactions: A narrative review of clinical and pharmacovigilance concern. · 5/10 · Treatment Innovation
Aging, longevity, and population health
- PMID 42965503 · Polypharmacy and probability of reduced glomerular filtration rate differentiated by gender and hypertension status in older adults. · 6/10 · Public Health
Rare diseases with high unmet need
- PMID 42966626 · Route-aware Therapeutic Target Atlas for Desmoplastic Small Round Cell Tumor. · 6/10 · Drug Development
- PMID 42965891 · Morphological Characteristics and Diagnostic Challenges of Primary Thyroid Lymphoma in Fine-Needle Aspiration Cytology. · 6/10 · Diagnostics
- PMID 42965688 · Dual-vector nanoengineered mRNA-CRISPR delivery systems for precision gene therapy in choroidal melanoma. · 5/10 · Drug Development
💡 UNSOLICITED FINDS
- PMID 42966652 · Social and Environmental Exposures and the Developing Gut of Newborns With Congenital Heart Disease. · 6/10 · Feeding tubes, formula exposure, aortic cross-clamp, and socioeconomic status were associated with altered gut microbiome diversity.
- PMID 42966650 · Efficacy and Safety of Low-Dose Versus Standard-Dose Alteplase to Treat High-Risk Pulmonary Embolism. · 6/10 · In-hospital mortality did not differ significantly between groups (48% in the low-dose group vs 45% in the standard-dose group; P = .81).
- PMID 42966646 · Dysphagia in Patients With High-Flow Nasal Cannulas: Risk and Practice Implications. · 6/10 · Dysphagia was associated with intubation and prolonged intensive care unit stay.
- PMID 42966645 · Determining the Prevalence of Hospital-Acquired Anemia in the Intensive Care Unit at a Florida Hospital. · 6/10 · Although causality regarding phlebotomy was not directly measured, the high prevalence of HAA supports implementing blood conservation strategies to improve clinical outcomes and reduce iatrogenic blood loss.
📊 TODAY'S BREAKDOWN
- By research category: Diagnostics 7 | Drug Development 4 | Genomics/Precision Medicine 4 | Public Health 4 | Treatment Innovation 9
- By evidence maturity: Exploratory 24 | Validated 4
- By watchlist topic:
- Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): 9 reviewed / 4 kept / highest 6
- CBC-based diagnostics and machine learning in hematology: 0 reviewed / 0 kept / highest 0
- Early cancer detection (liquid biopsy, ctDNA, cfDNA): 1 reviewed / 0 kept / highest 0
- AI/ML in clinical diagnostics and imaging: 15 reviewed / 5 kept / highest 6
- Precision oncology and genomic medicine: 4 reviewed / 4 kept / highest 7
- Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 12 reviewed / 4 kept / highest 7
- Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 13 reviewed / 5 kept / highest 7
- Aging, longevity, and population health: 7 reviewed / 1 kept / highest 6
- Rare diseases with high unmet need: 3 reviewed / 3 kept / highest 6
- Sentinel scan (unsolicited finds): 10 reviewed / 4 kept / highest 6
- By source type: peer_reviewed 28 | preprint 0
- Topics with zero 8+ articles this run: Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma); CBC-based diagnostics and machine learning in hematology; Early cancer detection (liquid biopsy, ctDNA, cfDNA); AI/ML in clinical diagnostics and imaging; Precision oncology and genomic medicine; Novel therapeutics: immunotherapy, CAR-T, targeted therapy; Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk; Aging, longevity, and population health; Rare diseases with high unmet need; Sentinel scan (unsolicited finds)
🔧 RUN NOTES
- The 24-hour CRDT window produced more than five relevant retained records, so no 48-hour expansion was required.
- Complete per-topic coverage was achieved at caps of 15 candidates per watchlist topic and 10 for sentinel.
- All 72 unique PMIDs were fetched from both ESummary and EFetch; oversized XML responses were recovered individually.
- Same-date rerun output was regenerated in full. Duplicate Telegram alerts remain suppressed outside this handoff.